Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Beauty Health CoSKINW 47 Debt-to-EBITDA is 9.08 as of Jun. 2026, which is 35% above its 10-year median of 6.75. GuruFocus rates SKINW with a GF Score™ of 47/100. The stock has 4 warning signs investors should review. Among 1,572 Consumer Packaged Goods companies, The Beauty Health Co ranks worse than 92.94% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for The Beauty Health Co's Debt-to-EBITDA or its related term are showing as below:
SKINW'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -80.95 Med: 6.75 Max: 39.07
Current: 14.12
During the past 8 years, the highest Debt-to-EBITDA Ratio of The Beauty Health Co was 39.07. The lowest was -80.95. And the median was 6.75.
SKINW's Debt-to-EBITDA is ranked worse than 92.94% of 1572
companies
in the Consumer Packaged Goods industry
Industry Median: 2.115
vs SKINW: 14.12
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The Beauty Health Co Debt-to-EBITDA Related Terms
The Beauty Health Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for The Beauty Health Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKINW vs SLSN, GROV, UG: Debt-to-EBITDA Comparison
For the Household & Personal Products subindustry, The Beauty Health Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Beauty Health Co Debt-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, The Beauty Health Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where The Beauty Health Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
The Beauty Health Co (SKINW) has a Debt-to-EBITDA of 9.08 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on The Beauty Health Co. This is 35% above median its historical median of 6.75. According to the industry distribution chart, The Beauty Health Co ranks #1461 out of 1572 companies in the Consumer Packaged Goods industry, placing it in the top 92.9%.
Is The Beauty Health Co's Debt-to-EBITDA too high?
The Beauty Health Co's current Debt-to-EBITDA of 9.08 is 35% above median its 10-year median of 6.75. The Consumer Packaged Goods industry median Debt-to-EBITDA is 2.12. The Beauty Health Co's value of 9.08 is 329.3% above this industry median. Based on the distribution chart, The Beauty Health Co ranks #1461 out of 1572 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, The Beauty Health Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does The Beauty Health Co's Debt-to-EBITDA compare to SLSN and GROV?
According to the Consumer Packaged Goods industry distribution chart, The Beauty Health Co ranks #1461 out of 1572 companies for Debt-to-EBITDA. This places The Beauty Health Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.12. The Beauty Health Co's value of 9.08 is 329.3% above this benchmark. While the company's 10-year median is 6.75 vs. the industry median of 2.12, The Beauty Health Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.12, based on 1,572 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Beauty Health Co's current Debt-to-EBITDA of 9.08 is 329.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on The Beauty Health Co. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Beauty Health Co's current Debt-to-EBITDA is 9.08, which is 35% above median its own 10-year median of 6.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Beauty Health Co stock overvalued right now?
The Beauty Health Co (SKINW) has a current Debt-to-EBITDA of 9.08. The current Debt-to-EBITDA is 9.08, which is 35% above median its 10-year median of 6.75 and 329.3% above the Consumer Packaged Goods industry median of 2.12. The Beauty Health Co's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For The Beauty Health Co (SKINW), the current Debt-to-EBITDA is 9.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
47GF Score
Get the complete analysis for SKINW
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKINW has been successfully added to your 
